- £3.81bn
- £3.27bn
- $3.85bn
- 21
- 64
- 96
- 65
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 7.86 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -5.77% | ||
| Dividend Yield (f) | 3.11% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.46 | ||
| Price to Tang. Book | 1.62 | ||
| Price to Free Cashflow | 25.61 | ||
| Price to Sales | 1.25 | ||
| EV to EBITDA | 5.65 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.65% | ||
| Return on Equity | 23.98% | ||
| Operating Margin | 16.24% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 2,911.8 | 2,999.9 | 3,022.7 | 3,813.4 | 3,845.7 | 4,892.99 | 5,113.82 | 7.66% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -57.23 | -72.84 | +1026.02 | +36.43 | +182.9 | -16.13 | +8.86 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hiscox Ltd is a Bermuda-based diversified international insurance company. The Company is a holding company for subsidiaries involved in the business of insurance and reinsurance in Bermuda, the United States, the United Kingdom, Guernsey, Europe and Asia. The Company’s segments include Hiscox Retail, Hiscox London Market, Hiscox Re & ILS and Corporate Centre. The Hiscox Retail segment includes results of the Company’s retail business divisions in the United Kingdom, Europe, United States and Asia. The Hiscox UK and Hiscox Europe divisions underwrite personal and commercial lines of business. The Hiscox USA division comprises commercial, property and specialty businesses. The Hiscox London Market consists of the internationally traded insurance business, including lines in property, marine and energy, casualty and other specialty insurance lines. The Hiscox Re & ILS segment is the reinsurance division of the Company, combining the underwriting platforms in Bermuda and London.
Directors
- Robert Childs NEC (70)
- Hamayou Akbar Hussain CEO (49)
- Liz Breeze CFO
- Stephane Flaquet CEX
- Steve Langan CEX
- Kate Markham CEX
- Kathleen Reardon CEX
- Bob Thaker CEX
- Benjamin Walter CEX
- Amanda Brown CHO (52)
- James Millard CIN
- Ian Penny CIO
- Hanna Kam CRO
- Marc Wetherhill GCN (48)
- Joanne Musselle EDR (50)
- Grace Hanson OTH
- Paul Lawrence OTH
- Donna Demaio NID
- Michael Goodwin NID (62)
- Thomas Hurlimann NID (57)
- Colin Keogh NID
- Anne MacDonald NID (65)
- Constantinos Miranthis NID (57)
- Lynn Pike NID (64)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- September 6th, 2006
- Public Since
- November 15th, 2006
- No. of Employees
- 3,000
- Sector
- Insurance
- Industry
- Financials
- Exchange
London Stock Exchange- Shares in Issue
- 341,879,959
- Address
- Chesney House, 96 Pitts Bay Road, PEMBROKE, HM 08
- Web
- https://www.hiscoxgroup.com/
- Phone
- +1 4412788300
- Contact
- Yana O'Sullivan
- Auditors
- PricewaterhouseCoopers Ltd
Latest News for HSX
Upcoming Events for HSX
Half Year 2024 Hiscox Ltd Earnings Release
Similar to HSX
Admiral
London Stock Exchange
Aviva
London Stock Exchange
Beazley
London Stock Exchange
Cathay Financial Holding Co
London Stock Exchange
Chesnara
London Stock Exchange
FAQ
As of Today at 21:09 UTC, shares in Hiscox are trading at 1,113.00p. This share price information is delayed by 15 minutes.
Shares in Hiscox last closed at 1,113.00p and the price had moved by +1% over the past 365 days. In terms of relative price strength the Hiscox share price has underperformed the FTSE All Share Index by -5.15% over the past year.
The overall consensus recommendation for Hiscox is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Hiscox dividend yield is 2.67% based on the trailing twelve month period.
Last year, Hiscox paid a total dividend of $0.38, and it currently has a trailing dividend yield of 2.67%. We do not have any data on when Hiscox is to next pay dividends.
We do not have data on when Hiscox is to next pay dividends. The historic dividend yield on Hiscox shares is currently 2.67%.
To buy shares in Hiscox you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 1,113.00p, shares in Hiscox had a market capitalisation of £3.81bn.
Here are the trading details for Hiscox:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: HSX
Based on an overall assessment of its quality, value and momentum Hiscox is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Hiscox is 1,296.33p. That is 16.47% above the last closing price of 1,113.00p.
Analysts covering Hiscox currently have a consensus Earnings Per Share (EPS) forecast of $1.73 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hiscox. Over the past six months, its share price has outperformed the FTSE All Share Index by +0.82%.
As of the last closing price of 1,113.00p, shares in Hiscox were trading +3.19% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Hiscox PE ratio based on its reported earnings over the past 12 months is 7.86. The shares last closed at 1,113.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Hiscox's management team is headed by:
- Robert Childs - NEC
- Hamayou Akbar Hussain - CEO
- Liz Breeze - CFO
- Stephane Flaquet - CEX
- Steve Langan - CEX
- Kate Markham - CEX
- Kathleen Reardon - CEX
- Bob Thaker - CEX
- Benjamin Walter - CEX
- Amanda Brown - CHO
- James Millard - CIN
- Ian Penny - CIO
- Hanna Kam - CRO
- Marc Wetherhill - GCN
- Joanne Musselle - EDR
- Grace Hanson - OTH
- Paul Lawrence - OTH
- Donna Demaio - NID
- Michael Goodwin - NID
- Thomas Hurlimann - NID
- Colin Keogh - NID
- Anne MacDonald - NID
- Constantinos Miranthis - NID
- Lynn Pike - NID